Macrolide antibiotic. Inhibits protein synthesis (elongation) at the transpeptidation step. Binds to the 23S RNA of the 50S ribosomal subunit. Effective against Gram-negative and Gram-positive bacteria.
Product Details
| Formula: | C37H67NO13 |
| |
| MW: | 733.9 |
| |
| Source: | Isolated from Streptomyces erythreus. |
| |
| CAS: | 114-07-8 |
| |
| MI: | 14: 3681 |
| |
| RTECS: | KF4375000 |
| |
| Purity: | ≥85% (Assay on dry basis) |
| |
| Appearance: | White to off-white powder. |
| |
| Solubility: | Soluble in water (50mg/ml), 100% ethanol or methanol. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism: T. Tokairin, et al.; Br. J. Clin. Pharmacol.
60, 172 (2005),
Abstract;
Full Text
Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban: J.Q. Tran, et al.; J. Clin. Pharmacol.
39, 513 (1999),
Abstract;
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells: Y. Aoki & P.N. Kao; Antimicrob. Agents Chemother.
43, 2678 (1999),
Abstract;
Full Text
Inducible erythromycin resistance in bacteria: B. Weisblum; Br. Med. Bull.
40, 47 (1984),
Abstract;
